Innovator IBD 50 ETF (NYSEARCA:FFTY – Get Free Report) was the recipient of a large drop in short interest during the month of August. As of August 14th, there was short interest totaling 11,741 shares, a drop of 38.8% from the July 30th total of 19,190 shares. Currently, 0.5% of the shares of the company are sold short. Based on an average daily trading volume, of 22,301 shares, the days-to-cover ratio is currently 0.5 days.
Institutional Trading of Innovator IBD 50 ETF
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Guardian Wealth Advisors LLC NC acquired a new position in shares of Innovator IBD 50 ETF during the second quarter valued at about $507,000. Kraematon Investment Advisors Inc. acquired a new position in shares of Innovator IBD 50 ETF in the second quarter valued at $1,021,000. Concurrent Investment Advisors LLC lifted its position in Innovator IBD 50 ETF by 11.1% in the second quarter. Concurrent Investment Advisors LLC now owns 63,128 shares of the company’s stock worth $3,349,000 after purchasing an additional 6,321 shares during the period. KFG Wealth Management LLC acquired a new stake in Innovator IBD 50 ETF during the second quarter worth $201,000. Finally, WorthPointe LLC lifted its holdings in shares of Innovator IBD 50 ETF by 18.3% during the 2nd quarter. WorthPointe LLC now owns 24,412 shares of the company’s stock worth $1,295,000 after acquiring an additional 3,771 shares during the period.
Innovator IBD 50 ETF Price Performance
Shares of NYSEARCA FFTY opened at $36.58 on Monday. Innovator IBD 50 ETF has a 12 month low of $31.61 and a 12 month high of $44.08. The company has a market cap of $78.65 million, a P/E ratio of 30.34 and a beta of 1.47. The business’s 50 day moving average is $38.76 and its two-hundred day moving average is $38.47.
Innovator IBD 50 ETF Company Profile
The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.
Further Reading
- Five stocks we like better than Innovator IBD 50 ETF
- Strike a Balance Between Growth and Stability With These 3 Names Ready to Rally
- Rubrik’s AI Security Bet Could Power the Next Leg Higher
- Apple’s Foldable iPhone Could Be a Catalyst, But Not a Cure-All
- Snowflake Is Up Nearly 50% in 2026—What Are Short Sellers Betting Against?
Receive News & Ratings for Innovator IBD 50 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD 50 ETF and related companies with MarketBeat.com's FREE daily email newsletter.
